2-[2-(2-甲氧基乙氧基)乙氧基]丙烷 | 77078-22-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-[2-(2-甲氧基乙氧基)乙氧基]丙烷
• 中文别名: 二乙二醇异丙基甲醚
• 英文名称: 2-[2-(2-Methoxyethoxy)ethoxy]propane
• CAS: 77078-22-9
• 化学式: C₈H₁₈O₃
• 分子量: 162.23
• InChiKey: RJBIZCOYFBKBIM-UHFFFAOYSA-N

物化性质

• 沸点：
  184.5±15.0 °C(Predicted)
• 密度：
  0.903～0.913g/mL (20℃)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  11
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• CONVERSION OF 2,3-BUTANEDIOL TO BUTADIENE
  申请人：Battelle Memorial Institute

  公开号：US20150218062A1

  公开（公告）日：2015-08-06

  A composition comprising 2,3-butanediol is dehydrated to methyl vinyl carbinol and/or 1,3-butadiene by exposure to a catalyst comprising (a) M x O y wherein M is a rare earth metal, a group IIIA metal, Zr, or a combination thereof, and x and y are based upon an oxidation state of M, or (b) M 3 a (PO 4 ) b where M 3 is a group IA, a group IIA metal, a group IIIA metal, or a combination thereof, and a and b are based upon the oxidation state of M 3 . Embodiments of the catalyst comprising M x O y may further include M 2 , wherein M 2 is a rare earth metal, a group IIA metal, Zr, Al, or a combination thereof. In some embodiments, 2,3-butanediol is dehydrated to methyl vinyl carbinol and/or 1,3-butadiene by a catalyst comprising M x O y , and the methyl vinyl carbinol is subsequently dehydrated to 1,3-butadiene by exposure to a solid acid catalyst.

  一种包括2,3-丁二醇的组合物通过暴露于催化剂而被脱水成为甲基乙烯醇和/或1,3-丁二烯，所述催化剂包括(a) MxOy，其中M是稀土金属、III A族金属、锆或二者的组合物，x和y基于M的氧化态，或(b) M3a(PO4)b，其中M3是IA族金属、IIA族金属、III A族金属或二者的组合物，a和b基于M3的氧化态。包括MxOy的催化剂的实施例可能进一步包括M2，其中M2是稀土金属、IIA族金属、锆、铝或二者的组合物。在一些实施例中，2,3-丁二醇通过包括MxOy的催化剂被脱水成为甲基乙烯醇和/或1,3-丁二烯，然后通过暴露于固体酸催化剂将甲基乙烯醇进一步脱水成为1,3-丁二烯。
• POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION
  申请人：Kwansei Gakuin Educational Foundation

  公开号：US20180094000A1

  公开（公告）日：2018-04-05

  The objective of the invention is to provide a polycyclic aromatic compound in which solubility to a solvent, film formability, wet coatability, thermal stability, and in-plane orientation are improved. This objective is achieved by a light emission layer-forming composition comprising: as a first component, at least one type of dopant material selected from the group consisting of polycyclic aromatic compounds represented by general formula (A) and polycyclic aromatic oligomer compounds including a plurality of structures represented by general formula (A); as a second component, a specific low-molecular-weight host material; and, as a third component, at least one type of organic solvent. In formula (A), ring A, ring B, and ring C each independently represent an aryl ring or a hetero aryl ring, Y 1 is B, and X 1 and X 2 each independently represent O or N—R wherein at least one of X 1 and X 2 is N—R.

  该发明的目的是提供一种多环芳香化合物，其溶解性、膜形成性、湿涂性、热稳定性和平面取向性得到改善。通过包括以下组分的发光层形成组合物实现这一目标：作为第一组分，至少一种从一般式（A）表示的多环芳香化合物和包括多个从一般式（A）表示的结构的多环芳香寡聚物化合物中选择的掺杂材料；作为第二组分，特定的低分子量载体材料；作为第三组分，至少一种有机溶剂。在式（A）中，环A、环B和环C分别独立表示芳基环或杂环芳基环，Y1是B，X1和X2分别独立表示O或N—R，其中X1和X2中至少一个是N—R。
• Cannabinoid receptor modulators
  申请人：Chackalamannil Samuel

  公开号：US20070197628A1

  公开（公告）日：2007-08-23

  A compound having the general structure of Formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, is useful in treating diseases, disorders, or conditions such as obesity, metabolic disorders, addiction, diseases of the central nervous system, cardiovascular disorders, respiratory disorders, and gastrointestinal disorders.

  具有通式（I）的一种化合物：或其药用盐、溶剂合物或酯，可用于治疗肥胖、代谢紊乱、成瘾、中枢神经系统疾病、心血管疾病、呼吸系统疾病和消化系统疾病等疾病、紊乱或症状。
• [EN] MTORC MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MTORC ET LEURS UTILISATIONS
  申请人：AEOVIAN PHARMACEUTICALS INC

  公开号：WO2020154447A1

  公开（公告）日：2020-07-30

  Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.

  本文披露了新型雷帕霉素类似物及其用途。本公开的雷帕霉素类似物相对于雷帕霉素表现出增加的mTORC1特异性和降低的mTORC2特异性。
• DERIVATIVES OF XANTHONE COMPOUNDS
  申请人：Zou Hanxun

  公开号：US20140349918A1

  公开（公告）日：2014-11-27

  The present invention relates to xanthone analogs. Such compounds may be used in the treatment of bacterial infections.

  本发明涉及黄酮类似物。这些化合物可用于治疗细菌感染。